ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 60 filers reported holding ESSA PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,722 | +288.6% | 7,677 | +239.5% | 0.00% | – |
| Q2 2023 | $6,105 | -9.1% | 2,261 | 0.0% | 0.00% | – |
| Q1 2023 | $6,715 | -98.7% | 2,261 | -97.3% | 0.00% | – |
| Q1 2022 | $525,000 | -56.9% | 85,069 | -0.7% | 0.00% | – |
| Q4 2021 | $1,217,000 | +86.4% | 85,638 | +4.9% | 0.00% | – |
| Q3 2021 | $653,000 | -65.6% | 81,638 | +23.0% | 0.00% | – |
| Q2 2021 | $1,897,000 | +4115.6% | 66,387 | +1668.0% | 0.00% | – |
| Q4 2020 | $45,000 | +73.1% | 3,755 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | +100.0% | 3,755 | +76.7% | 0.00% | – |
| Q2 2020 | $13,000 | – | 2,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |